Tri Locum Partners LP Sarepta Therapeutics, Inc. Transaction History

Tri Locum Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $3.61 Million - $4.79 Million	-30,734 Reduced 25.68%	88,961 $12.3 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $2.45 Million - $3.2 Million	24,250 Added 25.41%	119,695 $15.5 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $7.23 Million - $11.4 Million	95,445 New	95,445 $10.6 Million
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $10.4 Million - $13.4 Million	-135,055 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $8.91 Million - $12.5 Million	135,055 New	135,055 $12.5 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

Stay updated on Tri Locum Partners LP with notifications on news.